Free Review Articles on Diabetes mellitus T2DM (Type2)                                 Metatextbook

Freie Reviews über Diabetes mellitus (Typ2)                                 Look here for Journal Homepages

  • Diabetes mellitus T2DM (Type2)
  • Insulin (Analogs)
  • Polyamines
  • Arterial hypertension (BASKET)
  • Premedication and perioperative medicine
  • beta cell (Pancreas)
  • Cdkal1
  • RNA (tRNA)
  • Genome wide association study
  • Diabetes mellitus T1DM (Type1)
  • Mitochondria (BASKET)
  • Amylin
  • Ketoacidosis
  • Gliptin
  • Endoplasmic reticulum (ER stress)
  • Unfolded protein response
  • Transporter (Sodium and glucose)
  • Kidney (Tubulus)
  • SGLT2
  • Dapagliflozin
  • Laboratory animal (BASKET)
  • Testosterone
  • AMP activated protein kinase
  • Exercise (Physiology)
  • SIRT1
  • NAMPT
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12008Prediabetes: prevalent and preventable but underdiagnosed and undertreated.



    		+-nlManag Care 17(12):33-4, 40 (2008)
    22009Redefining the role of thiazolidinediones in the management of type 2 diabetes.



    		+-nlVasc Health Risk Manag 5(1):141-51 (2009)
    32007Optimizing combination treatment in the management of type 2 diabetes.



    		+-nlVasc Health Risk Manag 3(5):665-71 (2007)
    42010Self-monitoring of blood glucose in type 2 diabetes: systematic review.



    		+-nlHealth Technol Assess 14(12):1-140 (2010)
    52008The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review.



    		+-nlHealth Technol Assess 12(9):1-116, iii (2008)
    62008Cost-effectiveness of insulin analogs.



    		+-nlAm J Manag Care 14(11):766-75 (2008)
    72008Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.



    		+-nlAm J Manag Care 14(1):25-30 (2008)
    82005A systematic review of diabetes disease management programs.



    		+-nlAm J Manag Care 11(4):242-50 (2005)
    92003Prevention of the complications of diabetes.



    		+-nlAm J Manag Care 9(3 Suppl):S63-80; quiz S81-4 (2003)
    102002Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.



    		+-nlAm J Manag Care 8(16 Suppl):S460-71 (2002)
    111997Diabetes management: current diagnostic criteria, drug therapies, and state legislation.



    		+-nlAm J Manag Care 3(10):1599-608; quiz 1161-4 (1997)
    121974Manifestations of diabetes mellitus--their possible relationships to an underlying cell defect. A review.



    		+-nlAm J Pathol 75(1):204-24 (1974)
    132008Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.



    		+-nlAnn Intern Med 149(8):549-59 (2008)
    142007Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.



    		+-nlAnn Intern Med 147(6):386-99 (2007)
    152006Narrative review: a rational approach to starting insulin therapy.



    		+-nlAnn Intern Med 145(2):125-34 (2006)
    161988The biochemistry of diabetes.



    		+-nlBiochem J 250(3):625-40 (1988)
    171964DIABETES MELLITUS. A REVIEW OF SOME RECENT INVESTIGATIONS INTO THE NATURE OF THE CLINICAL SYNDROME.



    		+-nlCalif Med 100(-):1-9 (1964)
    182005Diagnosis and classification of diabetes mellitus.



    		+-nlDiabetes Care 28 Suppl 1(-):S37-42 (2005)
    192004Diabetes complications.



    		+-nlDiabetes Care 27(6):1506-14 (2004)
    202004Diagnosis and classification of diabetes mellitus.



    		+-nlDiabetes Care 27 Suppl 1(-):S5-S10 (2004)
    212003Pharmacologic treatment of type 2 diabetes.



    		+-nlDiabetes Care 26(2):526-33 (2003)
    222003Report of the expert committee on the diagnosis and classification of diabetes mellitus.



    		+-nlDiabetes Care 26 Suppl 1(-):S5-20 (2003)
    232002Standards of medical care for patients with diabetes mellitus.



    		+-nlDiabetes Care 25(1):213-29 (2002)
    242006Postprandial hyperglycaemia: to treat or not to treat?



    		+-nlDiabetes Metab 32(2):105-11 (2006)
    252006Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities.



    		+-nlDiabetes Metab 32(1):7-13 (2006)
    262005Use of antidiabetic drugs in elderly patients.



    		+-nlDiabetes Metab 31 Spec No 2(-):5S98-5S104 (2005)
    272005An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives.



    		+-nlDiabetes Metab 31(2):101-9 (2005)
    282008Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008.



    		+-nlJ Clin Endocrinol Metab 93(12):4633-42 (2008)
    292008Approach to the patient with prediabetes.



    		+-nlJ Clin Endocrinol Metab 93(9):3259-65 (2008)
    302008A new look at screening and diagnosing diabetes mellitus.



    		+-nlJ Clin Endocrinol Metab 93(7):2447-53 (2008)
    312002Clinical review 146: The impact of clinical trials on the treatment of diabetes mellitus.



    		+-nlJ Clin Endocrinol Metab 87(5):1929-37 (2002)
    322001Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.



    		+-nlJ Clin Endocrinol Metab 86(9):4047-58 (2001)
    331999Clinical review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment.



    		+-nlJ Clin Endocrinol Metab 84(4):1165-71 (1999)
    342006Islet beta cell failure in type 2 diabetes.



    		+-nlJ Clin Invest 116(7):1802-12 (2006) Prentki M
    351987Lipoprotein metabolism in diabetes mellitus.



    		+-nlJ Lipid Res 28(6):613-28 (1987)
    362005Insulin glargine: a long acting insulin analog.



    		+-nlJ Postgrad Med 51(1):68-71 (2005)
    372003Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.



    		+-nlMayo Clin Proc 78(4):459-67 (2003) Chan JL
    382003Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus.



    		+-nlMayo Clin Proc 78(4):447-56 (2003) Gerich JE
    391994New concepts in diabetes mellitus. II: Complications.



    		+-nlPostgrad Med J 70(825):479-85 (1994)
    401994New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.



    		+-nlPostgrad Med J 70(824):418-27 (1994)
    411990Diabetes mellitus.



    		+-nlPostgrad Med J 66(782):1010-24 (1990)
    421985Polyamines in clinical disorders.



    		+-nlWest J Med 142(1):63-73 (1985)
    432009Cost-effectiveness of insulin analogues for diabetes mellitus.



    		+-nlCMAJ 180(4):400-7 (2009) Cameron CG
    442009Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.



    		+-nlCMAJ 180(4):385-97 (2009) Singh SR
    452005Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.



    		+-nlCMAJ 173(12):1457-66 (2005)
    461991Non-insulin-dependent (type II) diabetes mellitus.



    		+-nlCMAJ 145(12):1571-81 (1991)
    472010Starting insulin therapy for type-2 diabetes.



    		+-nlActa Med Indones 42(2):116-20 (2010)
    482002Alternative therapies for type 2 diabetes.



    		+-nlAltern Med Rev 7(1):45-58 (2002)
    492010The effects of biofeedback in diabetes and essential hypertension.



    		+-nlCleve Clin J Med 77 Suppl 3(-):S68-71 (2010)
    502011Insulin treatment for type 2 diabetes: when to start, which to use.



    		+-nlCleve Clin J Med 78(5):332-42 (2011)
    512011How to manage type 2 diabetes in medical and surgical patients in the hospital.



    		+-nlCleve Clin J Med 78(6):379-84 (2011)
    522009Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.



    		+-nlCleve Clin J Med 76 Suppl 5(-):S12-9 (2009)
    532009Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects.



    		+-nlCleve Clin J Med 76 Suppl 5(-):S39-47 (2009)
    542009Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.



    		+-nlCleve Clin J Med 76 Suppl 5(-):S4-11 (2009)
    552009Managing diabetes in hemodialysis patients: observations and recommendations.



    		+-nlCleve Clin J Med 76(11):649-55 (2009)
    562011Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.



    		+-nlMayo Clin Proc 86(2):128-38 (2011)
    572010Defining and achieving treatment success in patients with type 2 diabetes mellitus.



    		+-nlMayo Clin Proc 85(12 Suppl):S50-9 (2010)
    582009Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?



    		+-nlNephrol Dial Transplant 24(2):338-41 (2009)
    592009Management of progressive type 2 diabetes: role of insulin therapy.



    		+-nlOsteopath Med Prim Care 3(-):5 (2009)
    602010Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus.



    		+-nlJ Clin Endocrinol Metab 95(9):4206-16 (2010)
    612009Update on nonautoimmune diabetes in children.



    		+-nlJ Clin Endocrinol Metab 94(7):2215-20 (2009)
    622002Insights into molecular pathogenesis of type 2 diabetes from knockout mouse models.



    		+-nlEndocr J 49(3):247-63 (2002)
    632011Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes [Review].



    		+-nlEndocr J 58(10):819-25 (2011)
    642011Genetics of type 2 diabetes: the GWAS era and future perspectives [Review].



    		+-nlEndocr J 58(9):723-39 (2011)
    652007American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.



    		+-nlEndocr Pract 13 Suppl 1(-):1-68 (2007)
    662009Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.



    		+-nlEndocr Pract 15(6):540-59 (2009)
    672010The role of mitochondria in the pathogenesis of type 2 diabetes.



    		+-nlEndocr Rev 31(3):364-95 (2010)
    682008Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.



    		+-nlEndocr Rev 29(3):303-16 (2008) Haataja L
    692008Syndromes of ketosis-prone diabetes mellitus.



    		+-nlEndocr Rev 29(3):292-302 (2008)
    702008Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.



    		+-nlEndocr Rev 29(3):367-79 (2008)
    712008The role for endoplasmic reticulum stress in diabetes mellitus.



    		+-nlEndocr Rev 29(1):42-61 (2008)
    722008The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.



    		+-nlEndocr Rev 29(3):317-33 (2008) Scheuner D
    732009Pathomechanisms of type 2 diabetes genes.



    		+-nlEndocr Rev 30(6):557-85 (2009)
    742011A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors.



    		+-nlDiscov Med 11(58):255-63 (2011)
    752009Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon.



    		+-nlArq Bras Endocrinol Metabol 53(2):165-74 (2009)
    762007Type 2 diabetes mellitus--guidelines for initiating insulin therapy.



    		+-nlAust Fam Physician 36(7):549-53 (2007)
    772007Animal models in type 2 diabetes research: an overview.



    		+-nlIndian J Med Res 125(3):451-72 (2007)
    782009The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.



    		+-nlJ Androl 30(1):23-32 (2009)
    792009Complementary and alternative medicine for the treatment of type 2 diabetes.



    		+-nlCan Fam Physician 55(6):591-6 (2009)
    802009Targeting the AMPK pathway for the treatment of Type 2 diabetes.



    		+-nlFront Biosci 14(-):3380-400 (2009)
    812009Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes.



    		+-nlFront Biosci 14(-):2983-95 (2009)
    822008New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies.



    		+-nlClin J Am Soc Nephrol 3 Suppl 2(-):S38-48 (2008)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.